Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Downgrades Bionomics to Neutral

HC Wainwright & Co. Downgrades Bionomics to Neutral

HC Wainwright & Co. analyst Joseph Pantginis downgrades Bionomics (NASDAQ:BNOX) from Buy to Neutral.

byBenzinga Newsdesk

December 19, 2022

1 minute read

HC Wainwright & Co. analyst Joseph Pantginis downgrades Bionomics (NASDAQ:BNOX) from Buy to Neutral.

Apple Watch Now Directly Syncs With Dexcom’s G7 Glucose Monitor

By Ananya Gairola

June 9, 11:07 PM

Dexcom Inc. has enabled direct Apple Watch connectivity for its G7 glucose monitor, allowing users to access real-time glucose data without needing an iPhone.

AAPL

Analyst Ratings

Analyst Ratings for Booking Holdings

By Benzinga Insights

November 22, 5:01 PM

Analysts have provided the following ratings for Booking Holdings (NASDAQ:BKNG) within the last quarter: Bullish Somewhat Bullish Indifferent…

BKNG

Reported Late Monday March 13, Everest Medicines Announces Partner Calliditas Therapeutics Reports Topline Results From Phase 3 NefIgArd Trial Evaluating Nefecon In IgA Nephropathy; Trial Primary Endpoint Was Met With Nefecon

By Happy Mohamed

March 14, 1:10 AM

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company") announced today that its partner Calliditas Therapeutics AB (NASDAQ:CALT, Nasdaq Stockholm: CALTX)))) ("Calliditas") reported

CALT